Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2024-08-01 Sale |
2024-08-05 4:28 pm |
Cerevel Therapeutics Holdings Inc. | CERE | DEKKERS MARIJN E Director |
444,609 | $0 | $0 | 0 (Indirect Direct) |
View |
| 2024-05-16 Sale |
2024-05-20 4:54 pm |
Ginkgo Bioworks Holdings Inc. | DNA | DEKKERS MARIJN E Director |
265,000 | $0.8303 | $220,030 | 5,796,581 (Indirect Direct) |
View |
| 2024-05-14 Sale |
2024-05-14 5:13 pm |
Ginkgo Bioworks Holdings Inc. | DNA | DEKKERS MARIJN E Director |
1,727,056 | $0.93 | $1,606,162 | 6,061,581 (Indirect Direct) |
View |
| 2023-06-15 Sale |
2023-06-20 4:56 pm |
Cerevel Therapeutics Holdings Inc. | CERE | DEKKERS MARIJN E Director |
200,000 | $34.43 | $6,886,000 | 434,148 (Indirect Direct) |
View |
| 2022-11-03 Sale |
2022-11-07 9:34 pm |
Ginkgo Bioworks Holdings Inc. | DNA | DEKKERS MARIJN E Director |
171,455 | $2.56 | $438,925 | 7,801,496 (Indirect Direct) |
View |
| 2021-06-04 Sale |
2021-06-08 4:19 pm |
Quanterix Corp | QTRX | DEKKERS MARIJN E Director |
16,661 | $55.52 | $925,077 | 7,002 (Direct) |
View |
| 2021-01-11 Sale |
2021-01-13 5:01 pm |
Quanterix Corp | QTRX | DEKKERS MARIJN E Director |
44,962 | $48.65 | $2,187,514 | 11,031 (Direct) |
View |
| 2020-08-07 Sale |
2020-08-11 4:52 pm |
Quanterix Corp | QTRX | DEKKERS MARIJN E Director |
27,619 | $32.49 | $897,341 | 6,810 (Indirect Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2024-06-12 Exercise |
2024-06-14 4:22 pm |
N/A N/A |
Ginkgo Bioworks Holdings Inc. | DNA | DEKKERS MARIJN E Director |
105,263 | $0 | 5,901,844 (Direct) |
View |
| 2024-06-05 Option Award |
2024-06-07 4:34 pm |
N/A N/A |
Cerevel Therapeutics Holdings Inc. | CERE | DEKKERS MARIJN E Director |
10,461 | $0 | 444,609 (Direct) |
View |
| 2023-06-16 Option Award |
2023-06-21 5:04 pm |
N/A N/A |
Ginkgo Bioworks Holdings Inc. | DNA | DEKKERS MARIJN E Director |
245,123 | $0 | 245,123 (Direct) |
View |
| 2023-06-07 Option Award |
2023-06-09 4:15 pm |
N/A 2033-06-07 |
Cerevel Therapeutics Holdings Inc. | CERE | DEKKERS MARIJN E Director |
17,062 | $0 | 647,928 (Direct) |
View |
Ownership |
2023-06-08 6:09 pm |
N/A N/A |
Telesis Bio Inc. | TBIO | Novalis LifeSciences Investments II GP LLC Novalis LifeSciences Investments II L.P. MEISTER PAUL M DEKKERS MARIJN E 10% Owner |
0 | $0 | 16,396,564 (Indirect) |
View |
Ownership |
2023-02-14 5:52 pm |
N/A N/A |
Cerevel Therapeutics Holdings Inc. | CERE | DEKKERS MARIJN E Director |
0 | $0 | 630,866 (Indirect) |
View |
| 2022-12-21 Ownership |
2023-02-14 5:52 pm |
N/A N/A |
Cerevel Therapeutics Holdings Inc. | CERE | DEKKERS MARIJN E Director |
14,270 | $0 | 630,866 (Direct) |
View |
| 2022-06-14 Option Award |
2022-06-16 4:46 pm |
N/A 2032-06-14 |
Cerevel Therapeutics Holdings Inc. | CERE | DEKKERS MARIJN E Director |
23,459 | $0 | 23,459 (Direct) |
View |
| 2022-06-10 Option Award |
2022-06-13 9:17 pm |
N/A 2032-06-10 |
Ginkgo Bioworks Holdings Inc. | DNA | DEKKERS MARIJN E Director |
179,437 | $0 | 8,081,467 (Direct) |
View |
| 2022-05-11 Option Award |
2022-05-13 4:17 pm |
N/A 2032-05-11 |
Quantum-Si Inc | QSI | DEKKERS MARIJN E Director |
59,880 | $0 | 59,880 (Direct) |
View |
| 2022-03-11 Option Award |
2022-03-14 9:33 pm |
N/A N/A |
Ginkgo Bioworks Holdings Inc. | DNA | DEKKERS MARIJN E Director |
1,746,706 | $0 | 7,902,030 (Direct) |
View |
| 2021-09-24 Exercise |
2021-09-28 4:10 pm |
N/A N/A |
Cerevel Therapeutics Holdings Inc. | CERE | DEKKERS MARIJN E Director |
14,270 | $0 | 676,160 (Direct) |
View |
| 2021-09-16 Option Award |
2021-09-20 9:44 pm |
N/A N/A |
Ginkgo Bioworks Holdings Inc. | DNA | DEKKERS MARIJN E Director |
6,155,324 | $0 | 6,155,324 (Direct) |
View |
| 2021-06-10 Option Award |
2021-06-14 8:09 pm |
N/A 2031-06-10 |
Cerevel Therapeutics Holdings Inc. | CERE | DEKKERS MARIJN E Director |
58,003 | $0 | 58,003 (Direct) |
View |
| 2021-06-10 Option Award |
2021-06-14 6:53 pm |
N/A N/A |
Quantum-Si Inc | QSI | DEKKERS MARIJN E Director |
500,000 | $10 | 670,512 (Indirect) |
View |
| 2021-06-10 Option Award |
2021-06-14 6:53 pm |
N/A N/A |
Quantum-Si Inc | QSI | DEKKERS MARIJN E Director |
170,512 | $0 | 670,512 (Direct) |
View |
| 2021-06-04 Exercise |
2021-06-08 4:19 pm |
N/A N/A |
Quanterix Corp | QTRX | DEKKERS MARIJN E Director |
1,951 | $8.16 | 7,002 (Direct) |
View |
| 2021-06-04 Exercise |
2021-06-08 4:19 pm |
N/A N/A |
Quanterix Corp | QTRX | DEKKERS MARIJN E Director |
7,900 | $23.12 | 7,002 (Direct) |
View |
| 2021-06-04 Exercise |
2021-06-08 4:19 pm |
N/A 2027-03-31 |
Quanterix Corp | QTRX | DEKKERS MARIJN E Director |
9,851 | $0 | 7,002 (Direct) |
View |
| 2021-01-11 Exercise |
2021-01-13 5:01 pm |
N/A N/A |
Quanterix Corp | QTRX | DEKKERS MARIJN E Director |
29,162 | $8.16 | 11,031 (Direct) |
View |
| 2021-01-11 Exercise |
2021-01-13 5:01 pm |
N/A N/A |
Quanterix Corp | QTRX | DEKKERS MARIJN E Director |
7,900 | $18.24 | 11,031 (Direct) |
View |
| 2021-01-11 Exercise |
2021-01-13 5:01 pm |
N/A N/A |
Quanterix Corp | QTRX | DEKKERS MARIJN E Director |
7,900 | $14.8 | 11,031 (Direct) |
View |
| 2021-01-11 Exercise |
2021-01-13 5:01 pm |
2019-12-31 2029-01-02 |
Quanterix Corp | QTRX | DEKKERS MARIJN E Director |
44,962 | $0 | 11,031 (Direct) |
View |
| 2021-01-04 Option Award |
2021-01-05 6:08 pm |
2021-12-31 2031-01-04 |
Quanterix Corp | QTRX | DEKKERS MARIJN E Director |
10,170 | $0 | 16,980 (Direct) |
View |
Ownership |
2020-10-30 8:00 pm |
N/A N/A |
Cerevel Therapeutics Holdings Inc. | CERE | DEKKERS MARIJN E Director |
0 | $0 | 42,810 (Direct) |
View |